7 Mid-Cap Stocks With the Highest Gains in April
On April 28, 2026, Reuters reported that Americans are extremely dissatisfied with the rising cost of living and the ongoing war with Iran.
Soleno Therapeutics Inc (SLNO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 447,300 | $14,975,604 | 0.02% | |
| 2. | Hudson Bay Capital Management Sander Gerber | 203,291 | $6,806,183 | +59868% | 0.02% |
| 3. | Centiva Capital Karim Abbadi And Edward Mcbride | 101,234 | $3,389,314 | -15% | 0.02% |
| 4. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 90,184 | $2,207,336 | +44% | 0.71% |
| 5. | Anson Investments Amin Nathoo And Moez Kassam | 44,231 | $1,480,854 | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 250,000 | $5,000,000.00 | 3,074,542 | 2023-09-28 | Filing | |
| $21.00 | 36,939 | $775,719.00 | 2,824,542 | 2023-09-26 | Filing | |
| $20.03 | 117,996 | $2,363,459.88 | 2,787,603 | 2023-09-26 | Filing | |
| $19.11 | 88,685 | $1,694,770.35 | 2,669,607 | 2023-09-26 | Filing | |
| $18.24 | 52,691 | $961,083.84 | 2,580,922 | 2023-09-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.72 | 558 | $17,699.03 | 64,507 | 2026-03-27 | Filing | |
| $31.04 | 2,100 | $65,180.64 | 65,065 | 2026-03-27 | Filing | |
| $30.04 | 4,864 | $146,099.97 | 67,165 | 2026-03-27 | Filing | |
| $31.72 | 488 | $15,478.73 | 39,823 | 2026-03-27 | Filing | |
| $31.04 | 1,838 | $57,048.58 | 40,311 | 2026-03-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,742,774 | $125,308,074 | 0% | |
| 2. | 2,153,218 | $72,089,739 | 0% | |
| 3. | 835,178 | $27,961,773 | 0.01% | |
| 4. | 616,217 | $20,630,945 | 0.02% | |
| 5. | 477,321 | $15,980,707 | 0% |
News See All
10 Stocks With Unexpected Gains
Ten stocks kicked off the trading week with significant gains, mirroring Wall Street's broader optimism, as investors cheered strong US jobs data while waiting on the sidelines for developments on the...
Soleno Therapeutics’ (SLNO) Investor Sentiment Subdued Amid Growth Concerns
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter.
7 Best Small-Cap Healthcare Stocks to Buy According to Hedge Funds
In this article, we will look at the best small-cap healthcare stocks to buy according to hedge funds.
H.C. Wainwright Lowers PT on Soleno (SLNO), Keeps a Buy Rating
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the Best Small-Cap Growth Stocks to Buy According to Hedge Funds. On March 4, H.C.
12 Best Small-Cap Growth Stocks to Buy According to Hedge Funds
On February 5, Simeon Hyman, Global Investment Strategist at ProShares, appeared on a Schwab Network interview to discuss how investors can capitalize on market rotation.
Soleno Therapeutics, Inc. (SLNO) Revenue Tops Expectations With $91.7M in Q4 Results, TD Cowen Maintains Buy
Soleno Therapeutics, Inc. (NASDAQ:SLNO) ranks among the most shorted stocks to buy according to analysts. On February 25, Soleno Therapeutics, Inc.
Wells Fargo Cuts PT on Soleno Therapeutics (SLNO) to $110 From $114 - Here's Why
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the best cheap biotech stocks to buy now. Wells Fargo cut the price target on Soleno Therapeutics, Inc.
12 Cheap Biotech Stocks to Buy Now
On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
11 Most Shorted Stocks to Buy According to Analysts
Although holes are starting to form, the stock market doesn't seem to be in danger of crashing just yet, with the S&P 500 down only 1% from its record high.
Hedge Fund Resource Center